Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2004 1
2005 1
2006 1
2009 2
2010 4
2011 11
2012 17
2013 18
2014 10
2015 20
2016 15
2017 18
2018 7
2019 15
2020 18
2021 25
2022 23
2023 21
2024 14
2025 12
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
[XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)].
Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A. Fernández Ó, et al. Among authors: oreja guevara c. Rev Neurol. 2026 Jan 21;81(1):39227. doi: 10.31083/RN39227. Rev Neurol. 2026. PMID: 41609134 Free PMC article. Review. Spanish.
[XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)].
Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A. Fernández Ó, et al. Among authors: oreja guevara c. Rev Neurol. 2026 Jan 21;81(1):39228. doi: 10.31083/RN39228. Rev Neurol. 2026. PMID: 41609133 Free PMC article. Review. Spanish.
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.
Aerts S, Geys L, Severijns D, Alkhawajah M, Berger T, Boyko A, Grigoriadis N, Hartung HP, Magyari M, Oreja-Guevara C, Pozzilli C, Vermersch P, Yamout B, Zakaria M, Ziemssen T, Popescu V, Peeters LM, Van Wijmeersch B. Aerts S, et al. Among authors: oreja guevara c. J Neurol Sci. 2026 Feb 15;481:125756. doi: 10.1016/j.jns.2026.125756. Epub 2026 Jan 14. J Neurol Sci. 2026. PMID: 41570412
Mitochondrial function of peripheral lymphocytes: role on multiple sclerosis clinical subtypes.
González-Jiménez A, de Heras-Pino P, Moreno-Jerez A, Mena-Plaza E, Aladro Y, Pilo B, Oreja-Guevara C, Gómez-Estévez I, López-Pastor AR, Gómez-Delgado I, Urcelay E. González-Jiménez A, et al. Among authors: oreja guevara c. Life Sci. 2026 Feb 15;387:124196. doi: 10.1016/j.lfs.2026.124196. Epub 2026 Jan 5. Life Sci. 2026. PMID: 41500383 Free article.
Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlook.
Klotz L, Berger T, Brownlee WJ, Chan A, Lycke J, Oreja-Guevara C, Palavra F, Sacca F, Sejbaek T, Weber MS, Giovannoni G. Klotz L, et al. Among authors: oreja guevara c. Ther Adv Neurol Disord. 2025 Sep 16;18:17562864251372752. doi: 10.1177/17562864251372752. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 40969774 Free PMC article. Review.
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Hauser SL, Cohen JA, de Sèze J, Meuth SG, Giacomini PS, Nakahara J, Oreja-Guevara C, Robertson D, Wray S, Bhatt A, Hu X, Xi J, Piccolo R, Jehl V, Sullivan R, Boer I, Wiendl H, Kappos L. Hauser SL, et al. Among authors: oreja guevara c. Neurol Ther. 2025 Oct;14(5):1975-1992. doi: 10.1007/s40120-025-00784-0. Epub 2025 Jul 13. Neurol Ther. 2025. PMID: 40652442 Free PMC article.
The role of microglia in multiple sclerosis: implications for treatment with Bruton's tyrosine kinase inhibitors.
Vermersch P, Airas L, Berger T, Deisenhammer F, Grigoriadis N, Hartung HP, Magyari M, Popescu V, Pozzilli C, Pugliatti M, Van Wijmeersch B, Zakaria M, Oreja-Guevara C. Vermersch P, et al. Among authors: oreja guevara c. Front Immunol. 2025 May 15;16:1495529. doi: 10.3389/fimmu.2025.1495529. eCollection 2025. Front Immunol. 2025. PMID: 40443664 Free PMC article. Review.
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists.
Berger T, Zeitlinger M, Popescu V, Magyari M, Airas L, Alkhawajah M, Pugliatti M, Zakaria M, Pozzilli C, Drulovic J, Van Wijmeersch B, Vermersch P, Oreja-Guevara C. Berger T, et al. Among authors: oreja guevara c. Eur J Neurol. 2025 Apr;32(4):e70140. doi: 10.1111/ene.70140. Eur J Neurol. 2025. PMID: 40231751 Free PMC article. Review.
218 results